Nanox.ARC to Undergo Orthopedic Imaging Clinical Study with Meir Medical Center
NNOX sits 16% above its 52-week low of $2.11.
Summary
Nano-X Imaging Ltd. (NNOX) has announced a clinical collaboration with Meir Medical Center, a significant healthcare provider in Israel, to conduct a clinical study utilizing its Nanox.ARC system for orthopedic imaging. This initiative aims to validate the diagnostic capabilities of Nanox.ARC for orthopedic injuries, demonstrating its potential to offer more detailed anatomical information, enhance diagnostic confidence, and accelerate clinical decision-making compared to traditional methods, while also reducing radiation dose. This collaboration is a crucial step in building the necessary clinical evidence base to support the broader adoption and commercialization of the Nanox.ARC system, following recent distribution agreements for the product. Investors will be watching for the outcomes of this study as a key indicator of the product's market potential and future growth.
At the time of this announcement, NNOX was trading at $2.44 on NASDAQ in the Life Sciences sector, with a market capitalization of approximately $151.8M. The 52-week trading range was $2.11 to $5.86. This news item was assessed with positive market sentiment and an importance score of 7 out of 10. Source: GlobeNewswire.